Avalo Therapeutics Announces Leadership Transition : vimarsana.com

Promotes Dr. Garry Neil to Chief Executive Officer Promotes Chris Sullivan to Chief Financial Officer

Related Keywords

Chris Sullivan , Schond Greenway , Garry Neil , Mike Cola , Maxim Jacobs , Steven Boyd , Astra Merck , Chris Brinzey Westwicke , Foundation For The National Institutes Of Health , College Park , University Of Maryland , Avalo Therapeutics Inc , Board Of The Center , Gtx Pharmaceuticals , Nasdaq , Industry Rd Consortium , University Of Saskatchewan , Transcelerate Biopharmaceuticals Inc , Hackensack Meridian Health , Johnson Pharmaceutical Research , Phrma Foundation Board , Board Of Directors Arena Pharmaceuticals , Company We , Company Board Of Directors , University Of Saskatchewan College Medicine , Regulatory Executive Committee , Science Technology At Johnson , Board Of The Reagan Udall Foundation , Ernst Young , Manufacturers Association Phrma Science , Sucampo Pharmaceuticals , Clinical Research At Astrazeneca , Chief Executive Officer Promotes Chris Sullivan , Chief Financial , Chief Scientific Officer , Chief Executive Officer , Chief Accounting Officer , Chief Financial Officer , Arena Pharmaceuticals , Hackensack Meridian , Aevi Genomic Medicine , Group President , Clinical Research , Pharmaceutical Industry Rd Consortium , Pharmaceutical Research , Manufacturers Association , Reagan Udall Foundation , National Institutes , Science Management Review Board , Saskatchewan College , Interim Chief Financial Officer , Corporate Controller , Senior Manager , Certified Public , Avalo Therapeutics , Looking Statements This , Private Securities Litigation Reform Act , Brinzey Westwicke , Vice President , Investor Relations Avalo Therapeutics , Money , Ational ,